The Tufts Center for the Study of Drug Development (Tufts CSDD) at Tufts School of Medicine, is the only independent, multi-disciplinary academic research center committed to providing objective, scholarly, and empirical research, analysis, and data-driven insights on trends and practices impacting global clinical trial planning and execution. Tufts CSDD has been at the forefront of assessing drug development innovation, time, cost, efficiency, and risk through robust, data-driven assessments and analysis. For more details, visit Tufts CSDD